failure to respond or late response
on 11 May 2019
Last Applicant/ Owned by
794 Sunrise Blvd.
Mount Bethel
PA
18343
Serial Number
87523966 filed on 11th Jul 2017
Registration Number
N/A
Correspondent Address
GARY D.E. PIERCE
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary and nutritional supplements; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary food supplements; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary supplements; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary Read More
Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary and nutritional supplements; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary food supplements; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary supplements; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary supplements for improving cognitive function; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary supplements for reducing inflammation; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary supplements for managing symptoms of PTSD; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary supplements for managing opioid withdrawal; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of pharmaceutical preparations for the treatment of and for improving cognitive function; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of pharmaceutical preparations for the treatment of and for reducing inflammation; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of pharmaceutical preparations for the treatment of and for managing opioid withdrawal; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of pharmaceutical preparations for the treatment of and for managing symptoms of PTSD
15th Dec 2017
15th Dec 2017
No 87523966
No Service/Collective Mark
No 3340-3-41
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 13th May 2019 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 11th May 2019 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 13th Oct 2018 | FINAL REFUSAL E-MAILED |
| 13th Oct 2018 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 13th Oct 2018 | SU - FINAL REFUSAL - WRITTEN |
| 19th Sep 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 18th Sep 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 18th Sep 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 13th Sep 2018 | NON-FINAL ACTION E-MAILED |
| 13th Sep 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
